5/7/2014 9:06:42 AM
SAN DIEGO, May 6, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will report financial results for the first quarter ended March 31, 2014, after the market close on Tuesday, May 13, 2014. Conatus will host a conference call and audio webcast at 4:30 p.m. Eastern Time on Tuesday, May 13, 2014, to discuss the financial results and provide a corporate update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by